AR and lung adenocarcinoma: Treatment with AhR ligand benzo[α]pyrene (BaP) tremendously reduced constitutive AR expression as well as testosterone-induced AR protein levels in lung adenocarcinoma cells while TCDD did not reduce AR levels [33].